The law firm of Gary C. Johnson, P.S.C., is currently accepting cases for individuals who have been diagnosed with various forms of cancer after regular, repeated use of the popular antacid Zantac. On September 13, 2019, the U.S. Food and Drug Administration (FDA) initiated an investigation of the drug after claims that it may be contaminated with unacceptable levels of a known carcinogen. Since then, they have begun numerous voluntary recalls of Zantac and its numerous generic forms.
If you or a loved one have contracted cancer due to regular prescription Zantac use, please contact us immediately to discuss your case. Our Zantac cancer lawsuit lawyers are committed to seeking justice on behalf of our clients.
At the law firm of Gary C. Johnson, P.S.C., we have the experience, knowledge, and compassion to get our clients the results they deserve.
Serious injuries and diseases require an aggressive, results-oriented approach – and we are here to fight for you.
Zantac is the most popular brand name version of the drug ranitidine, an over-the-counter antacid and popular heartburn medication. Manufactured by pharmaceutical company Sanofi, Zantac (and its generic forms) is used as needed for those who are suffering from acute heartburn – while it is also used regularly for those with more serious acid problems, such as acid reflux or gastroesophageal reflux disease (GERD).
In 2019, abnormally high levels of N-nitrosodimethylamine (NDMA) were found in a normal over-the-counter form of the drug by a third-party lab analysis. NDMA is a probable human carcinogen that has a high chance of causing cancer in those who ingest it. According to research, a single dose of Zantac can expose the human body to NDMA levels thousands of times higher than the FDA deems safe.
Further testing of Zantac revealed that the active ingredient, ranitidine, had the potential to metabolize into NDMA under certain conditions. Repeat testing confirmed this finding, with high levels of NDMA exposure found in other retail Zantac packages – despite manufacturers claiming that generic ranitidine only broke down into NDMA in extreme heat.
While under investigation, the FDA recommended a voluntary recall of all Zantac, and Sanofi complied.
Since the first recall was announced in September 2019, 14 additional recalls of drugs containing ranitidine were initiated by the FDA. As of January 8th, 2020, the complete list of recalls includes the following manufacturers:
Zantac users may have had an increased risk of certain types of cancers. These cancer risks include:
It is important to note that those who have used Zantac as needed to treat acute heartburn are currently not considered to be at high risk of the above cancer. However, those who have used generic ranitidine products regularly once or twice a day for at least one year to treat GERD and other similar disorders have the highest risk of contracting cancer.
If you or a loved one have been diagnosed with the above cancers after at least one year of regular ranitidine use, please contact an experienced Lexington personal injury attorney immediately to discuss your case. You may be eligible for significant compensation for injuries resulting from defective drugs.
At the law firm of Gary C. Johnson, P.S.C., we are currently seeking clients with the following criteria:
Those who have started and/or stopped smoking in the past 25 years may not qualify, depending on the type of cancer. However, you may still be eligible for some form of compensation. Please contact us for more information regarding your potential case.
Pharmaceutical companies have a duty to patients and customers to ensure their drugs are effectively treating the symptoms and disorders that are advertised. Additionally, they have a responsibility to test their products on a regular basis to confirm the positive effects of said drug.
All those who manufacture ranitidine tablets and other products, such as Zantac, failed to test their drugs to ensure that they could not break down into NDMA under the most routine conditions. Additionally, the inherently unstable nature of ranitidine suggests that the drug was never actually safe to begin with due to an inherent defect in the product – a defect that arguably would have been discovered had proper testing been done on the drug.
By failing to uphold their duty of care in their products, these pharmaceutical companies exhibited gross negligence – and should thus be held accountable for their actions.
If you or a loved one have had a cancer diagnosis after at least one year of regular Zantac use, please contact us immediately to discuss your case during a free consultation. You are not alone in this, and we will help you fight to receive the compensation and closure you deserve for your pain and suffering. A Zantac cancer lawsuit can help you recuperate many of the damages you’ve been dealt.
Our law firm represents victims of Zantac lawsuits in Lexington, KY and across the United States.
“The most professional group of attorneys that I have ever worked with. They are not only professional but caring as well. They were there for me at one of the most difficult times in my life. They listened to what I had to say, and they truly cared about what I was enduring and supported me 110%. I highly recommend this law firm if you are ever in need of an attorney.” – Janice C.